Hypertensive Management in the Asymptomatic Patient: First do no harm Steven A Godwin MD, FACEP University of Florida, COM-Jacksonville Ponte Vedra 2007.

Slides:



Advertisements
Similar presentations
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
Advertisements

1 ENVOLVING THE FUTURE OF SINGLE PILL COMBINATION IN ANTIHYPERTENSIVE THERAPHY Djanggan Sargowo Shangri-La, Surabaya - Sabtu, 23 Juni 2012.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
Lifestyle Modifications for the Prevention and Management of Hypertension ANDREAS PITTARAS MD.
Burden of Cardiovascular Disease in Mississippi. Top Ten Leading Causes of Death in Mississippi, 2007 Source: Mississippi Vital Statistics, 2007.
TROPHY TRial Of Preventing HYpertension. High-normal BP increases CV risk Vasan RS et al. N Engl J Med. 2001;345: Incidence of CV events in women.
Hypertension and The Kidney Update: Clinical Trials Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine.
The Rationale for Initiating Therapy with Fixed-Dose Combinations in Hypertension Thomas D. Giles, M.D. Tulane University School of Medicine New Orleans,
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Hypertension and Stroke
Pranay Kathuria, MD, FACP, FASN, FNKF Director, Division of Nephrology
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Edward P. Sloan, MD, MPH, FACEP Emergency Department Patient Hypertensive Emergencies: Published Guidelines, Articles, & Their Findings.
Screening Guidelines and Treatment Options for Abdominal Aortic Aneurysms Allen Jeremias, MD Division of Cardiology B eth I srael D eaconess M edical C.
Hypertension in the Elderly
Diabetic Nephropathy Yiming Lit, M.D. May 5, 2009.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
QUALITY USE OF CARDIOVASCULAR MEDICATION Dr Mark Abelson.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
on behalf of the INVEST Investigators
DR. IDOWU AKOLADE EDM DIVISION LUTH
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Daily Dilemmas in Hypertension Management. Objectives Review the impact of hypertension on society Review the impact of hypertension on society Review.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Is It the Achieved Blood Pressure or Specific Medications that Make a Difference in Outcome, or Is the Question Moot? William C. Cushman, MD Professor,
Increased Blood Pressure in the Emergency Department: Pain, Anxiety, or Undiagnosed Hypertension AHRQ Annual Meeting 2008 Paula Tanabe, PhD, MPH, RN Northwestern.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
1 Improving Chronic Care Management David M. Cutler Presented at Alliance for Health Reform Novartis/NIHCM Briefing March 28, 2008.
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.
PPAR  activation Clinical evidence. Evolution of clinical evidence supporting PPAR  activation and beyond Surrogate outcomes studies Large.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
1 Current & New treatment strategies to address CV Risk.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Salt, Heart Disease, and Stroke Norm Campbell. 1) The role of increased blood pressure as a determinant of adverse outcomes 2) The health risks of high.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
NDAs /772 Etoricoxib Robert B. Shibuya, M.D. Medical Officer Division of Anesthesia, Analgesia, and Rheumatology Products.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Chocolate Sweetens Fight Against High Blood Pressure for Some By: Karen Kaplan Los Angeles Times Presented By: Dan Pastor.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
2007 Hypertension as a Public Health Risk January, 2007.
Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.
December 02 1 Vascular mortality: Age-specific hazard ratios for 20 mmHg lower usual SBP deaths at ages
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Antonio Coca, MD, PhD, FRCP, FESC
William C. Cushman, MD Chief, Preventive Medicine Section,
Hypertension In The Stroke Patient
Hypertension guidelines What’s all the controversy about 2015
OBESITY OBESITY What’s New in the 2017 Version? The Obesity Algorithm is reviewed and updated yearly to reflect the newest and most relevant information.
Blood Pressure and Age in Controlling Hypertension
Flowchart of participants
United States Preventive Services Task Force: Recommendations for ABPM
Improving Chronic Care Management
Teaching Tool: Blood Pressure Classification
Managing Complex Hypertension: What Every Physician Should Know
Managing Hard-To-Treat Hypertension: What Every Physician Should Know
JNC Evidence-Based Guideline for the Management of
Presentation transcript:

Hypertensive Management in the Asymptomatic Patient: First do no harm Steven A Godwin MD, FACEP University of Florida, COM-Jacksonville Ponte Vedra 2007

Case Presentation 42 yo obese male presents complaining of chronic knee pain with no acute injury. He is otherwise asymptomatic but… 42 yo obese male presents complaining of chronic knee pain with no acute injury. He is otherwise asymptomatic but… Triage Vitals- BP 210/115 Triage Vitals- BP 210/115 Now what? Now what?

Background HTN affects 50 million people in the US and approximately 1 billion world wide HTN affects 50 million people in the US and approximately 1 billion world wide Normotensive patients at age 55 have a 90% lifetime risk for development Normotensive patients at age 55 have a 90% lifetime risk for development JNC 7

Question #1 Initiation of medical management is recommended at which level of BP? Initiation of medical management is recommended at which level of BP? A. 120/75 B. 140/90 C. 135/80 D. 160/100

Prehypertension Significant risk for progression to hypertension Significant risk for progression to hypertension Patients in the 130–139/80–89 mmHg BP range are at twice the risk to develop hypertension as those with lower values. Patients in the 130–139/80–89 mmHg BP range are at twice the risk to develop hypertension as those with lower values. Chobanian AV et al,. [The JNC 7 Report]. JAMA Vasan RS et al. N Engl J Med

Increased CVD Risk Patients yrs double their CVD risk with each increment of 20 mmHg SBP or Patients yrs double their CVD risk with each increment of 20 mmHg SBP or 10 mmHg DBP from 115/75 to 185 mmHg Lewington S et al. Lancet Chobanian AV et al,. [The JNC 7 Report]. JAMA

Question 2 Are blood pressure measurements accurate for screening for asymptomatic hypertension in the ED? Are blood pressure measurements accurate for screening for asymptomatic hypertension in the ED? A. Yes B. No

ACEP Recommendations Are ED BP readings accurate and reliable for screening asymptomatic patients for HTN? Are ED BP readings accurate and reliable for screening asymptomatic patients for HTN? Level B - If 2 or more measurements are elevated with a SBP > 140 mmHg or Level B - If 2 or more measurements are elevated with a SBP > 140 mmHg or DBP > 90 mmHg, the patient should be referred for follow-up for possible HTN and appropriate BP management Level C – Pts with 1 elevated BP reading may require further screening in the outpt setting Level C – Pts with 1 elevated BP reading may require further screening in the outpt setting

Is there Benefit with Acute Blood Pressure Reduction in Asymptomatic Patients? Beyond making us feel better?! Beyond making us feel better?!

Outcomes With and Without Treatment VA Coop Trial of RCT with placebo control VA Coop Trial of RCT with placebo control 143 pts with DBP pts with DBP No adverse outcomes with treatment versus placebo No adverse outcomes with treatment versus placebo 4 pts did develop significant complications after 4 months including sudden death, elevated Cr, CHF and ruptured AAA 4 pts did develop significant complications after 4 months including sudden death, elevated Cr, CHF and ruptured AAA

ACEP Recs for Asymptomatic HTN Level B- Level B- (1) Rapidly lowering BP is unnecessary and may be harmful in some pts. (2) Initiating treatment is not necessary when definitive follow-up is available (3) When ED treatment is initiated, BP should be lowered gradually and should not be expected to normalize in the ED

Future Areas of Research What is the acute work-up for asymptomatic hypertension in the ED? What is the acute work-up for asymptomatic hypertension in the ED? Some limited studies Some limited studies ferne_pv_2007_htn_godwin_062307_finalcd